Nationwide Recall Issued for Levothyroxine Sodium Thyroid Medication Due to Potency Issues

Major Pharmaceuticals has issued a nationwide Class II recall for several lots of levothyroxine sodium tablets, an often-prescribed thyroid medication, due to being subpotent. The recall, initially issued on July 13, was classified by the FDA on July 17, with the notice published this week. Levothyroxine sodium is used to treat hypothyroidism and can also be used to decrease enlarged thyroids or treat a form of thyroid cancer. A Class II recall indicates that use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.